BIM
CBST

BlackRock Investment Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

BlackRock Investment Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-206,484
Closed -$20.8M – 4197
2014
Q4 		$20.8M Sell
206,484
-83,529
-29% -$6.49M 0.03% 536
2014
Q3 		$19.2M Buy
290,013
+19,955
+7% +$1.31M 0.03% 543
2014
Q2 		$18.9M Buy
270,058
+19,123
+8% +$1.3M 0.03% 575
2014
Q1 		$18.4M Buy
250,935
+1,951
+0.8% +$145K 0.03% 554
2013
Q4 		$17.1M Buy
248,984
+20,826
+9% +$1.35M 0.03% 568
2013
Q3 		$14.5M Buy
228,158
+132,047
+137% +$7.98M 0.02% 614
2013
Q2 		$4.64M Buy
+96,111
New +$4.72M 0.01% 1268

BlackRock Investment Management's CBST Position: Q1 2015 in Review

BlackRock Investment Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 206,484 shares — an estimated $20.8M sold.

BlackRock Investment Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $20.8M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • BlackRock Investment Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 206,484 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $20.8M.
  • BlackRock Investment Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Investment Management's CUBIST PHARMACEUTICALS INC position peaked at $20.8M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Investment Management's 13F filing for Q1 2015, filed 13 May 2015.